ScoreWhy is Bal Pharma Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.24%
- Poor long term growth as Net Sales has grown by an annual rate of 7.71% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.53 times
2
Flat results in Dec 25
- ROCE(HY) Lowest at 8.99%
- INTEREST(Q) At Rs 4.85 cr has Grown at 25.65%
3
Stock is technically in a Mildly Bearish range
- Multiple factors for the stock are Bearish like RSI, MACD and KST
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -8.45% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bal Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bal Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bal Pharma
13.88%
-0.22
38.98%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.43%
EBIT Growth (5y)
5.67%
EBIT to Interest (avg)
1.26
Debt to EBITDA (avg)
4.78
Net Debt to Equity (avg)
1.83
Sales to Capital Employed (avg)
1.52
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
26.48%
Pledged Shares
0
Institutional Holding
0.15%
ROCE (avg)
9.59%
ROE (avg)
8.24%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
36
Price to Book Value
1.90
EV to EBIT
13.64
EV to EBITDA
9.06
EV to Capital Employed
1.32
EV to Sales
0.92
PEG Ratio
21.67
Dividend Yield
1.22%
ROCE (Latest)
8.96%
ROE (Latest)
7.64%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
DEBT-EQUITY RATIO(HY)
Lowest at 1.94 times
NET SALES(Q)
Highest at Rs 88.62 cr
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 7.21 cr
Loading Valuation Snapshot...
Here's what is working for Bal Pharma
Net Sales - Quarterly
Highest at Rs 88.62 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 88.62 cr has Grown at 34.54%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 1.94 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Bal Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 7.21 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
